Suppr超能文献

心力衰竭中心室心律失常的管理:当前观点

Management of ventricular arrhythmias in heart failure: Current perspectives.

作者信息

Peichl Petr, Rafaj Adam, Kautzner Josef

机构信息

Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

出版信息

Heart Rhythm O2. 2021 Dec 17;2(6Part B):796-806. doi: 10.1016/j.hroo.2021.08.007. eCollection 2021 Dec.

Abstract

Congestive heart failure (HF) is a progressive affliction defined as the inability of the heart to sufficiently maintain blood flow. Ventricular arrhythmias (VAs) are common in patients with HF, and conversely, advanced HF promotes the risk of VAs. Management of VA in HF requires a systematic, multimodality approach that comprises optimization of medical therapy and use of implantable cardioverter-defibrillator and/or device combined with cardiac resynchronization therapy. Catheter ablation is one of the most important strategies with the potential to abolish or decrease the number of recurrences of VA in this population. It can be a curative strategy in arrhythmia-induced cardiomyopathy and may even save lives in cases of an electrical storm. Additionally, modulation of the autonomic nervous system and stereotactic radiotherapy have been introduced as novel methods to control refractory VAs. In patients with end-stage HF and refractory VAs, an institution of the mechanical circulatory support device and cardiac transplant may be considered. This review aims to provide an overview of current evidence regarding management strategies of VAs in HF with an emphasis on interventional treatment.

摘要

充血性心力衰竭(HF)是一种进行性疾病,定义为心脏无法充分维持血流。室性心律失常(VAs)在HF患者中很常见,反之,晚期HF会增加VAs的风险。HF中VA的管理需要一种系统的多模式方法,包括优化药物治疗以及使用植入式心脏复律除颤器和/或结合心脏再同步治疗的设备。导管消融是最重要的策略之一,有可能消除或减少该人群中VA的复发次数。它在心律失常性心肌病中可能是一种治愈性策略,甚至在电风暴情况下可以挽救生命。此外,自主神经系统调节和立体定向放射治疗已被引入作为控制难治性VA的新方法。对于终末期HF和难治性VA患者,可考虑使用机械循环支持设备和心脏移植。本综述旨在概述目前关于HF中VA管理策略的证据,重点是介入治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a790/8710622/9f40eabfb3f8/gr1.jpg

相似文献

1
Management of ventricular arrhythmias in heart failure: Current perspectives.
Heart Rhythm O2. 2021 Dec 17;2(6Part B):796-806. doi: 10.1016/j.hroo.2021.08.007. eCollection 2021 Dec.
2
Ablation of ventricular arrhythmia in patients with heart failure.
Heart Fail Clin. 2015 Apr;11(2):319-36. doi: 10.1016/j.hfc.2014.12.009. Epub 2015 Feb 24.
3
Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators.
JACC Clin Electrophysiol. 2020 Mar;6(3):327-337. doi: 10.1016/j.jacep.2019.11.012. Epub 2020 Jan 29.
4
Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
J Am Coll Cardiol. 2017 Apr 11;69(14):1842-1860. doi: 10.1016/j.jacc.2017.01.047.
5
Ventricular Arrhythmias in Patients With Left Ventricular Assist Device (LVAD).
Curr Treat Options Cardiovasc Med. 2019 Nov 27;21(11):75. doi: 10.1007/s11936-019-0783-7.
6
The evaluation and management of electrical storm.
Tex Heart Inst J. 2011;38(2):111-21.
8
Heart failure as a substrate and trigger for ventricular tachycardia.
J Interv Card Electrophysiol. 2019 Dec;56(3):229-247. doi: 10.1007/s10840-019-00623-x. Epub 2019 Oct 9.
9
Ventricular arrhythmias in heart failure with reduced ejection fraction.
Curr Opin Cardiol. 2020 May;35(3):282-288. doi: 10.1097/HCO.0000000000000733.

引用本文的文献

1
Antiarrhythmic Treatment in Heart Failure.
Curr Heart Fail Rep. 2024 Feb;21(1):22-32. doi: 10.1007/s11897-023-00642-w. Epub 2024 Jan 15.
3
Basic Research Approaches to Evaluate Cardiac Arrhythmia in Heart Failure and Beyond.
Front Physiol. 2022 Feb 7;13:806366. doi: 10.3389/fphys.2022.806366. eCollection 2022.

本文引用的文献

1
Quinidine in the Management of Recurrent Ventricular Arrhythmias: A Reappraisal.
JACC Clin Electrophysiol. 2021 Oct;7(10):1254-1263. doi: 10.1016/j.jacep.2021.03.024. Epub 2021 Jun 30.
2
Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience.
JACC Clin Electrophysiol. 2020 Oct 26;6(11):1420-1431. doi: 10.1016/j.jacep.2020.07.023. Epub 2020 Sep 30.
3
Management of ventricular electrical storm: a contemporary appraisal.
Europace. 2020 Dec 23;22(12):1768-1780. doi: 10.1093/europace/euaa232.
4
The PROFID project.
Eur Heart J. 2020 Oct 14;41(39):3781-3782. doi: 10.1093/eurheartj/ehaa645.
5
Subcutaneous or Transvenous Defibrillator Therapy.
N Engl J Med. 2020 Aug 6;383(6):526-536. doi: 10.1056/NEJMoa1915932.
7
Acute and long-term results of bipolar radiofrequency catheter ablation of refractory ventricular arrhythmias of deep intramural origin.
Heart Rhythm. 2020 Sep;17(9):1500-1507. doi: 10.1016/j.hrthm.2020.04.028. Epub 2020 Apr 28.
8
Mechanical circulatory support for life-threatening arrhythmia: A systematic review.
Int J Cardiol. 2020 Jun 1;308:42-49. doi: 10.1016/j.ijcard.2020.03.045. Epub 2020 Mar 19.
9
Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia.
J Am Coll Cardiol. 2020 Mar 3;75(8):884-897. doi: 10.1016/j.jacc.2019.12.044.
10
Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses.
J Cardiovasc Electrophysiol. 2020 May;31(5):1009-1018. doi: 10.1111/jce.14404. Epub 2020 Mar 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验